Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (bbb).

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

Cordon‐Cardo, C., O’Brien, J. P., Casals, D., Rittmann-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750 · see citing works

Nanoparticulate systems for brain delivery of drugs.

Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · see citing works

Nanoparticulate systems for brain delivery of drugs

Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958 · see citing works

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801 · see citing works

Transport of drugs across the blood–brain barrier by nanoparticles.

Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715 · see citing works

Delivery of therapeutic agents to the central nervous system: the problems and the possibilities

Begley, D. J. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.001 · Cited by 679 · see citing works

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB)

Ulbrich, K., Hekmatara, T., Herbert, E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.021 · Cited by 591 · see citing works

Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)

Kreuter, J., Alyautdin, R. N., Kharkevich, D. A., & Aa, I. (1995) · Brain Research · doi:10.1016/0006-8993(95)00023-j · Cited by 538 · see citing works

Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles

Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521 · see citing works

Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles

Kreuter, J., Ramge, P., Petrov, V. E., Hamm, S., Gelperina, S. E., Engelhardt, B., Alyautdin, R. N., von Briesen, H., & Begley, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1022604120952 · Cited by 469 · see citing works

Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones

Zensi, A., Begley, D., Pontikis, C., Legros, C., Mihoreanu, L., Wagner, S., Büchel, C., von Briesen, H., & Kreuter, J. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.03.002 · Cited by 438 · see citing works

Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles

Steiniger, S. C. J., Kreuter, J., Khalansky, A. S., Skidan, I. N., Bobruskin, A. I., Smirnova, Z. S., Severin, E. S., Uhl, R., Kock, M., Geiger, K. D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20048 · Cited by 434 · see citing works

Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles

Alyautdin, R. N., Petrov, V. E., Langer, K., Berthold, A., Kharkevich, D. A., & Kreuter, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012098005098 · Cited by 352 · see citing works

Covalent Linkage of Apolipoprotein E to Albumin Nanoparticles Strongly Enhances Drug Transport into the Brain

Michaelis, K., Hoffmann, M. M., Dreis, S., Herbert, E., Alyautdin, R. N., Michaelis, M., Kreuter, J., & Langer, K. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.097139 · Cited by 346 · see citing works

Implications of the Blood-Brain Barrier and Its Manipulation

Neuwelt, E. A. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0701-3 · Cited by 316 · see citing works

Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: Revisiting the role of surfactants

Petri, B., Bootz, A., Khalansky, A. S., Hekmatara, T., Müller, R. H., Uhl, R., Kreuter, J., & Gelperina, S. E. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.015 · Cited by 299 · see citing works

Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: Influence of the formulation parameters

Gelperina, S. E., Maksimenko, O., Khalansky, A. S., Vanchugova, L. V., Шипуло, Е. В., Abbasova, K., Berdiev, R. K., Wohlfart, S., Chepurnova, N. E., & Kreuter, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.09.003 · Cited by 293 · see citing works

The Blood-brain Barrier: Principles for Targeting Peptides and Drugs to the Central Nervous System

Begley, D. J. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb07112.x · Cited by 291 · see citing works

The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux System

Nerurkar, M. M., Burton, P. S., & Borchardt, R. T. (1996) · Pharmaceutical Research · doi:10.1023/a:1016033702220 · Cited by 287 · see citing works

Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain

Kreuter, J., Hekmatara, T., Dreis, S., Vogel, T., Gelperina, S. E., & Langer, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.012 · Cited by 263 · see citing works

Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)

Ulbrich, K., Knobloch, T., & Kreuter, J. (2011) · Journal of Drug Targeting · doi:10.3109/10611861003734001 · Cited by 259 · see citing works

Reversal of multidrug resistance by surfactants

Woodcock, D., Linsenmeyer, M. E., Chojnowski, G. M., Kriegler, A., Nink, V., Webster, L., & Sawyer, W. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.217 · Cited by 233 · see citing works

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80–coated polybutylcyanoacrylate nanoparticles: Anin situbrain perfusion study

Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229 · see citing works

Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles

Kurakhmaeva, K. B., Djindjikhashvili, I. A., Petrov, V. E., Balabanyan, V. U., Voronina, T. A., Trofimov, S. S., Kreuter, J., Gelperina, S., Begley, D., & Alyautdin, R. N. (2009) · Journal of Drug Targeting · doi:10.1080/10611860903112842 · Cited by 221 · see citing works

Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity

Olivier, J.-C., Fenart, L., Chauvet, R., Pariat, C., Cecchelli, R., & Couet, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018947208597 · Cited by 213 · see citing works

Polysorbate‐80 coating enhances uptake of polybutylcyanoacrylate (PBCA)‐nanoparticles by human and bovine primary brain capillary endothelial cells

Ramge, P., Unger, R. E., Oltrogge, J. B., Zenker, D., Begley, D. J., Kreuter, J., & von Briesen, H. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00078.x · Cited by 197 · see citing works

Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles

Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196 · see citing works

Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma

Gelperina, S. E., Khalansky, A. S., Skidan, I. N., Smirnova, Z. S., Bobruskin, A. I., Severin, E. S., Turowski, B., Zanella, F., & Kreuter, J. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00456-8 · Cited by 185 · see citing works

Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrierin vivoandin vitro

Alyaudtin, R. N., Reichel, A., Löbenberg, R., Ramge, P., Kreuter, J., & Begley, D. J. (2001) · Journal of drug targeting · doi:10.3109/10611860108997929 · Cited by 166 · see citing works

Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers

Wohlfart, S., Khalansky, A. S., Gelperina, S. E., Maksimenko, O., Bernreuther, C., Glatzel, M., & Kreuter, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019121 · Cited by 162 · see citing works

Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles

Alyautdin, R. N., Gothier, D., Петров, Kharkevich, D. A., & Kreuter, J. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 148 · see citing works

Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system

Friese, A. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00073-9 · Cited by 140 · see citing works

Functional Protein Delivery into Neurons Using Polymeric Nanoparticles

Hasadsri, L., Kreuter, J., Hattori, H., Iwasaki, T., & George, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805956200 · Cited by 127 · see citing works

Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain

Zensi, A., Begley, D. J., Pontikis, C., Legros, C., Mihoreanu, L., Büchel, C., & Kreuter, J. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.513712 · Cited by 119 · see citing works

Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers

Borchard, G., Audus, K. L., Shi, F., & Kreuter, J. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90372-7 · Cited by 105 · see citing works

Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model

Ambruosi, A., Gelperina, S. E., Khalansky, A. S., Tanski, S., Theisen, A., & Kreuter, J. (2006) · Journal of Microencapsulation · doi:10.1080/02652040600788080 · Cited by 100 · see citing works

Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier

Wohlfart, S., Khalansky, A. S., Gelperina, S. E., Begley, D. J., & Kreuter, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.010 · Cited by 100 · see citing works

Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: Focus on cardio- and testicular toxicity

Переверзева, Э. Р., Трещалин, И. Д., Бодягин, Д. А., Максименко, О. О., Langer, K., Dreis, S., Asmussen, B., Kreuter, J., & Gelperina, S. E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.01.031 · Cited by 76 · see citing works

Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model

Wagner, S., Kufleitner, J., Zensi, A., Dadparvar, M., Wien, S., Bungert, J., Vogel, T., Worek, F., Kreuter, J., & von Briesen, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014213 · Cited by 69 · see citing works

Efficient systemic therapy of rat glioblastoma by nanoparticle-bound doxorubicin is due to antiangiogenic effects

Hekmatara, T., Bernreuther, C., Khalansky, A. S., Theisen, A., Weissenberger, J., Matschke, J., Gelperina, S. E., Kreuter, J., & Glatzel, M. (2009) · Clinical Neuropathology · doi:10.5414/npp28153 · Cited by 61 · see citing works

Cytotoxicity of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles in rat glioma cell lines using different assays

Juan, B. S. D., von Briesen, H., Gelperina, S. E., & Kreuter, J. (2006) · Journal of drug targeting · doi:10.1080/10611860600866872 · Cited by 49 · see citing works

Intravenous tolerance of a nanoparticle-based formulation of doxorubicin in healthy rats

Переверзева, Э. Р., Трещалин, И. Д., Бодягин, Д. А., Максименко, О. О., Kreuter, J., & Gelperina, S. E. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.01.020 · Cited by 47 · see citing works

Treatment of glioblastoma with poly(isohexyl cyanoacrylate) nanoparticles

Wohlfart, S., Khalansky, A. S., Bernreuther, C., Michaelis, M., Cinatl, J. J., Glatzel, M., & Kreuter, J. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.046 · Cited by 47 · see citing works

Ultrastructure of Brain Endothelium

Brightman, M. (1992) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-76894-1_1 · Cited by 45 · see citing works

Blood-Brain Barrier Disruption in the Treatment of Brain Tumors

Neuwelt, E. A., & Barnett, P. A. (1989) · Springer eBooks · doi:10.1007/978-1-4615-7255-8_4 · Cited by 44 · see citing works

Blood-Brain Barrier Disruption in the Treatment of Brain Tumors

Neuwelt, E. A., & Dahlborg, S. A. (1989) · Springer eBooks · doi:10.1007/978-1-4615-7255-8_5 · Cited by 44 · see citing works

Intracellular drug delivery using polysorbate 80-modified poly( D , L -lactide-co-glycolide) nanospheres to glioblastoma cells

Tahara, K., Kato, Y., Yamamoto, H., Kreuter, J., & Kawashimà, Y. (2010) · Journal of Microencapsulation · doi:10.3109/02652048.2010.522258 · Cited by 25 · see citing works

Increased Numbers of Injections of Doxorubicin Bound to Nanoparticles Lead to Enhanced Efficacy Against Rat Glioblastoma 101/8

Wohlfart, S., Bernreuther, C., Khalansky, A. S., Theisen, A., Weissenberger, J., Gelperina, S. E., Glatzel, M., & Kreuter, J. (2009) · Journal of Nanoneuroscience · doi:10.1166/jns.2009.1003 · Cited by 11 · see citing works

Nanoparticulate Carriers for Drug Delivery to the Brain

Kreuter, J. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860949074_0024 · Cited by 11 · see citing works

Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle

Saptarshi, S. R., Duschl, A., & Lopata, A. L. (2013) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-11-26 · Cited by 1,084 · see citing works

Current Strategies for Brain Drug Delivery

Dong, X. (2018) · Theranostics · doi:10.7150/thno.21254 · Cited by 954 · see citing works

Cancer nanomedicine: a review of recent success in drug delivery

Tran, S., DeGiovanni, P.-J., Piel, B. P., & Rai, P. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0175-0 · Cited by 943 · see citing works

Effect of the surface modification, size, and shape on cellular uptake of nanoparticles

Salatin, S., Dizaj, S. M., & Khosroushahi, A. Y. (2015) · Cell Biology International · doi:10.1002/cbin.10459 · Cited by 626 · see citing works

Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?

Kreuter, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.008 · Cited by 554 · see citing works

Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges

Zhang, W., Mehta, A., Tong, Z., Esser, L., & Voelcker, N. H. (2021) · Advanced Science · doi:10.1002/advs.202003937 · Cited by 430 · see citing works

Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

Naqvi, S., Panghal, A., & Flora, S. J. S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00494 · Cited by 305 · see citing works

Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes

Ghadiri, M., Young, P. M., & Traini, D. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030113 · Cited by 286 · see citing works

Nano carriers for drug transport across the blood–brain barrier

Li, X.-M., Tsibouklis, J., Weng, T., Zhang, B.-N., Yin, G.-Q., Feng, G.-Z., Cui, Y.-D., Savina, I., Mikhalovska, L., Sandeman, S., et al. (2017) · Journal of drug targeting (Print) · doi:10.1080/1061186x.2016.1184272 · Cited by 217 · see citing works

The protein corona and its effects on nanoparticle-based drug delivery systems

Li, H., Wang, Y., Tang, Q., Yin, D., Tang, C., He, E., Zou, L., & Peng, Q. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.019 · Cited by 265 · see citing works

PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier

Fornaguera, C., Dols-Pérez, A., Calderó, G., García, M. J. N., Camarasa, J., & Solans, C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.002 · Cited by 221 · see citing works

The Influence of Nanoparticle Shape on Protein Corona Formation

Visalakshan, R. M., García, L. E. G., Benzigar, M. R., Ghazaryan, A., Simon, J., Mierczynska-Vasilev, A. M., Michl, T. D., Vinu, A., Mailänder, V., Morsbach, S., et al. (2020) · Small · doi:10.1002/smll.202000285 · Cited by 202 · see citing works

Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier

Sharma, G., Sharma, A. R., Lee, S., Bhattacharya, M., Nam, J., & Chakraborty, C. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.056 · Cited by 194 · see citing works

Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders

Islam, S. U., Shehzad, A., Ahmed, M. B., & Lee, Y. S. (2020) · Molecules · doi:10.3390/molecules25081929 · Cited by 184 · see citing works

Targeting autophagy, oxidative stress, and ER stress for neurodegenerative disease treatment

Esmaeili, Y., Yarjanli, Z., Paknia, F., Bidram, E., Łoś, M., Eshraghi, M., Klionsky, D. J., Ghavami, S., & Zarrabi, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.001 · Cited by 180 · see citing works

Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities

Au, J. L. ‐., Yeung, B. Z., Wientjes, M. G., Lu, Z., & Wientjes, M. G. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.002 · Cited by 161 · see citing works

Branched and Dendritic Polymer Architectures: Functional Nanomaterials for Therapeutic Delivery

Cook, A. B., & Perrier, S. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201901001 · Cited by 163 · see citing works

A Multifunctional Polymeric Nanotheranostic System Delivers Doxorubicin and Imaging Agents across the Blood–Brain Barrier Targeting Brain Metastases of Breast Cancer

Li, J., Cai, P., Shalviri, A., Henderson, J. T., He, C., Foltz, W. D., Prasad, P., Brodersen, P. M., Chen, Y., DaCosta, R. S., et al. (2014) · ACS Nano · doi:10.1021/nn501069c · Cited by 155 · see citing works

Nanostructures: a platform for brain repair and augmentation

Vidu, R., Rahman, M., Mahmoudi, M., Enăchescu, M., Potecă, T. D., & Opriș, I. C. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00091 · Cited by 132 · see citing works

Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier

Tosi, G., Duskey, J. T., & Kreuter, J. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1698544 · Cited by 129 · see citing works

Glycocalyx degradation leads to blood–brain barrier dysfunction and brain edema after asphyxia cardiac arrest in rats

Zhu, J., Li, X., Yin, J., Hu, Y., Gu, Y., & Pan, S. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17726062 · Cited by 125 · see citing works

Stabilising cubosomes with Tween 80 as a step towards targeting lipid nanocarriers to the blood–brain barrier

Azhari, H. N., Strauss, M., Hook, S. M., Boyd, B. J., & Rizwan, S. B. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.05.001 · Cited by 118 · see citing works

Molybdenum Disulfide Nanoparticles as Multifunctional Inhibitors against Alzheimer’s Disease

Han, Q., Cai, S., Yang, L., Wang, X., Cui, Q., Yang, R., & Wang, C. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b03816 · Cited by 118 · see citing works

Brain imaging with near-infrared fluorophores

Wang, H., Mu, X., Jiang, Y., Liang, Y., Zhang, X., & Ming, D. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.11.003 · Cited by 119 · see citing works

Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma

Kim, S. S., Rait, A. S., Kim, E. H., DEMARCO, J. P., Pirollo, K. F., & Chang, E. H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.08.022 · Cited by 115 · see citing works

Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential

Agrahari, V., Burnouf, P., Burnouf, T. P. R., & Agrahari, V. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.02.008 · Cited by 114 · see citing works

Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy – an illustration with firsthand examples

Zhang, R., Li, J., Zhang, T., Amini, M. A., He, C., Lu, B., Ahmed, T., Lip, H., Rauth, A. M., & Wu, X. Y. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.33 · Cited by 112 · see citing works

Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells

Dufès, C., Al Robaian, M., & Somani, S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.21 · Cited by 110 · see citing works

Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases

Anthony, D. P., Hegde, M., Shetty, S. S., Rafic, T., Mutalik, S., & Rao, B. S. S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119326 · Cited by 110 · see citing works

Nanotechnology-based drug delivery for the treatment of CNS disorders

Mittal, K. R., Pharasi, N., Sarna, B., Singh, M., Rachana, R., Haider, S., Singh, S. K., Dua, K., Jha, S. K., Dey, A., et al. (2022) · Translational Neuroscience · doi:10.1515/tnsci-2022-0258 · Cited by 112 · see citing works

Blood-brain barrier-penetrating amphiphilic polymer nanoparticles deliver docetaxel for the treatment of brain metastases of triple negative breast cancer

He, C., Cai, P., Li, J., Zhang, T., Lin, L. Q., Abbasi, A. Z., Henderson, J. T., Rauth, A. M., & Wu, X. Y. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.019 · Cited by 103 · see citing works

The biocorona: a challenge for the biomedical application of nanoparticles

Shannahan, J. H. (2016) · Nanotechnology Reviews · doi:10.1515/ntrev-2016-0098 · Cited by 103 · see citing works

Systemic delivery to central nervous system by engineered PLGA nanoparticles.

Cai, Q., Wang, L., Deng, G., Liu, J., Chen, Q., & Chen, Z. (2016) · PubMed Central · Cited by 97 · see citing works

Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles)

Wu, V., Huynh, E., Tang, S., & Uskoković, V. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.01.064 · Cited by 91 · see citing works

Endothelial glycocalyx as an important factor in composition of blood‐brain barrier

Zhao, F., Zhong, L., & Luo, Y. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13560 · Cited by 91 · see citing works

Targeting neurotransmitter receptors with nanoparticles in vivo allows single-molecule tracking in acute brain slices

Varela, J. A., Dupuis, J. P., Etchepare, L., Espana, A., Cognet, L., & Groc, L. (2016) · Nature Communications · doi:10.1038/ncomms10947 · Cited by 86 · see citing works

Tailored theranostic apolipoprotein E3 porphyrin-lipid nanoparticles target glioblastoma

Rajora, M. A., Ding, L., Valic, M. S., Jiang, W., Overchuk, M., Chen, J., & Zheng, G. (2017) · Chemical Science · doi:10.1039/c7sc00732a · Cited by 85 · see citing works

Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation

Madani, F., Esnaashari, S. S., Bergonzi, M. C., Webster, T. J., Younes, H. M., Khosravani, M., & Adabi, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117943 · Cited by 82 · see citing works

Multitargeted Nanoparticles Deliver Synergistic Drugs across the Blood–Brain Barrier to Brain Metastases of Triple Negative Breast Cancer Cells and Tumor‐Associated Macrophages

Zhang, T., Lip, H., He, C., Cai, P., Wang, Z., Henderson, J. T., Rauth, A. M., & Wu, X. Y. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900543 · Cited by 83 · see citing works

Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels

Paul, D., Cowan, A. E., Ge, S., & Pachter, J. S. (2012) · Microvascular Research · doi:10.1016/j.mvr.2012.12.001 · Cited by 77 · see citing works

Dense poly(ethylene glycol) coatings maximize nanoparticle transport across lymphatic endothelial cells and accumulate in the skindraining lymph nodes

McCright, J., Skeen, C., Yarmovsky, J., & Maisel, K. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.03.054 · Cited by 79 · see citing works

Comparative examination of adsorption of serum proteins on HSA- and PLGA-based nanoparticles using SDS–PAGE and LC–MS

Gossmann, R., Fahrländer, E., Hummel, M., Mulac, D., Brockmeyer, J., & Langer, K. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.021 · Cited by 78 · see citing works

Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability

Piazzini, V., Landucci, E., Graverini, G., Pellegrini-Giampietro, D. E., Bilia, A. R., & Bergonzi, M. C. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030128 · Cited by 77 · see citing works

PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study

Arduino, I., Depalo, N., Re, F., Magro, R. D., Panniello, A., Margiotta, N., Fanizza, E., Lopalco, A., Laquintana, V., Cutrignelli, A., et al. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119351 · Cited by 70 · see citing works

The influence of the blood–brain barrier in the treatment of brain tumours

Rathi, S., Griffith, J. I. G., Zhang, W., Zhang, W., Oh, J., Talele, S., Sarkaria, J. N., & Elmquist, W. F. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13440 · Cited by 71 · see citing works

Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches

Yeini, E., Ofek, P., Albeck, N., Ajamil, D. R., Neufeld, L., Eldar‐Boock, A., Kleiner, R., Vaskovich‐Koubi, D., Koshrovski‐Michael, S., Dangoor, S. I., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000124 · Cited by 68 · see citing works

Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors

Griffith, J. I. G., Rathi, S., Zhang, W., Zhang, W., Drewes, L. R., Sarkaria, J. N., & Elmquist, W. F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121205 · Cited by 68 · see citing works

Stimuli‐Responsive Self‐Assembled DNA Nanomaterials for Biomedical Applications

Dai, Z., Leung, H. M., & Lo, P. K. (2016) · Small · doi:10.1002/smll.201602881 · Cited by 68 · see citing works

Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s Disease

Del Amo, L., Cano, A., Ettcheto, M., Souto, E. B., Espina, M., Camins, A., García, M. L., & Sánchez-López, E. (2021) · Applied Sciences · doi:10.3390/app11094305 · Cited by 67 · see citing works

Nanotechnology: Toxicologic Pathology

Hubbs, A. F., Sargent, L. M., Porter, D. W., Sager, T. M., Chen, B. T., Frazer, D. G., Castranova, V., Sriram, K., Nurkiewicz, T. R., Reynolds, S. H., et al. (2013) · Toxicologic Pathology · doi:10.1177/0192623312467403 · Cited by 67 · see citing works

Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease

Lauzon, M.-A., Daviau, A., Marcos, B., & Faucheux, N. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.024 · Cited by 65 · see citing works

Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier

Chaturvedi, M., Molino, Y., Sreedhar, B., Khrestchatisky, M., & Kaczmarek, L. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s54750 · Cited by 65 · see citing works

The use of polymer-based nanoparticles and nanostructured materials in treatment and diagnosis of cardiovascular diseases: Recent advances and emerging designs

Wang, Y.-J., Larsson, M., Huang, W.-T., Chiou, S., Nicholls, S. J., Chao, J., & Liu, D.-M. (2016) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2016.01.002 · Cited by 65 · see citing works

Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance

Rhaman, M. M., Islam, M. R., Akash, S., Mim, M., Noor alam, M., Nepovimova, E., Valis, M., Kuca, K., & Sharma, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.989471 · Cited by 63 · see citing works

Drug delivery across the blood-brain barrier for the treatment of pediatric brain tumors – An update

Power, E. A., Rechberger, J. S., Gupta, S. K., Schwartz, J., Daniels, D. J., & Khatua, S. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114303 · Cited by 62 · see citing works

Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases

Khalil, A., Barras, A., Boukherroub, R., Tseng, C., Devos, D., Burnouf, T. P. R., Neuhaus, W., & Szunerits, S. (2023) · Nanoscale Horizons · doi:10.1039/d3nh00306j · Cited by 62 · see citing works

Optimization of Curcumin-Loaded PEG-PLGA Nanoparticles by GSH Functionalization: Investigation of the Internalization Pathway in Neuronal Cells

Paka, G. D., & Ramassamy, C. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00738 · Cited by 62 · see citing works

Nano‐Biotechnology and Challenges of Drug Delivery System in Cancer Treatment Pathway: Review Article

Asadipour, E., Asgari, M., Mousavi, P., Gharaghie, T. P., Ghajari, G., & Mirzaie, A. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202201072 · Cited by 57 · see citing works

In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes

Lindqvist, A., Rip, J., van Kregten, J., Gaillard, P. J., & Hammarlund‐Udenaes, M. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1774-3 · Cited by 56 · see citing works

Enabling nanomaterial, nanofabrication and cellular technologies for nanoneuromedicines

Mallapragada, S. K., Brenza, T. M., McMillan, J., Narasimhan, B., Sakaguchi, D. S., Sharma, A. D., Zbarska, S., & Gendelman, H. E. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.12.013 · Cited by 54 · see citing works

Effects of Particle Hydrophobicity, Surface Charge, Media pH Value and Complexation with Human Serum Albumin on Drug Release Behavior of Mitoxantrone-Loaded Pullulan Nanoparticles

Tao, X., Jin, S., Wu, D., Ling, K., Yuan, L., Lin, P., Xie, Y., & Yang, X. (2015) · Nanomaterials · doi:10.3390/nano6010002 · Cited by 51 · see citing works

Evaluation of brain-targeted chitosan nanoparticles through blood–brain barrier cerebral microvessel endothelial cells

Şahin, A., Yöyen-Ermiş, D., Caban-Toktas, S., Horzum, U., Aktaş, Y., Couvreur, P., Esendağlı, G., & Çapan, Y. (2017) · Journal of Microencapsulation · doi:10.1080/02652048.2017.1375039 · Cited by 52 · see citing works

Transferrin-Coated Gadolinium Nanoparticles as MRI Contrast Agent

Korkusuz, H., Ulbrich, K., Welzel, K., Koeberle, V., Watcharin, W., Bahr, U., Chernikov, V. P., Knobloch, T., Petersen, S., Huebner, F., et al. (2012) · Molecular Imaging and Biology · doi:10.1007/s11307-012-0579-6 · Cited by 49 · see citing works

Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC/D3 cell line

Guccione, C., Oufir, M., Piazzini, V., Eigenmann, D. E., Jähne, E. A., Zabela, V., Faleschini, M. T., Bergonzi, M. C., Smieško, M., Hamburger, M. O., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.06.018 · Cited by 48 · see citing works

The uses of resveratrol for neurological diseases treatment and insights for nanotechnology based-drug delivery systems

Fonseca‐Santos, B., & Chorilli, M. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119832 · Cited by 46 · see citing works

Crossing the blood–brain barrier with graphene nanostructures

Tabish, T. A., & Narayan, R. J. (2021) · Materials Today · doi:10.1016/j.mattod.2021.08.013 · Cited by 47 · see citing works

Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection

DeMarino, C., Schwab, A., Pleet, M. L., Mathiesen, A. H., Friedman, J. M., El‐Hage, N., & Kashanchi, F. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9692-7 · Cited by 42 · see citing works

Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis

Marcianes, P., Negro, S., García‐García, L., Montejo, C., Barcia, E., & Fernández-Carballido, A. M. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s130908 · Cited by 42 · see citing works

Application of isothermal titration calorimetry in evaluation of protein–nanoparticle interactions

Omanović-Mikličanin, E., Manfield, I. W., & Wilkins, T. (2016) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-016-5764-4 · Cited by 41 · see citing works

Preparation and Drug Release Study of Novel Nanopharmaceuticals with Polysorbate 80 Surface Adsorption

Tao, X., Yu, L., Hu, Q., Zhu, L., Huang, Z., Yi, J., Yang, X., Hu, J., & Feng, X. (2018) · Journal of Nanomaterials · doi:10.1155/2018/4718045 · Cited by 41 · see citing works

Lactoferrin-conjugated pH and redox-sensitive polymersomes based on PEG-S-S-PLA-PCL-OH boost delivery of bacosides to the brain

Goyal, K., Konar, A., Kumar, B. S. H., & Koul, V. (2018) · Nanoscale · doi:10.1039/c8nr03828g · Cited by 38 · see citing works

Diagnostic and Therapeutic Uses of Nanomaterials in the Brain

Garbayo, E., de Mendoza, A. E., & Blanco‐Prieto, M. J. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140815124246 · Cited by 37 · see citing works

Comparative whole corona fingerprinting and protein adsorption thermodynamics of PLGA and PCL nanoparticles in human serum

Ndumiso, M., Buchtová, N., Hüsselmann, L., Mohamed, G., Klein, A., Aucamp, M. E., Canevet, D., D’Souza, S., Maphasa, R. E., Boury, F., et al. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.110816 · Cited by 37 · see citing works

Polysorbate 80-coated PLGA nanoparticles improve the permeability of acetylpuerarin and enhance its brain-protective effects in rats

Sun, D., Xue, A., Zhang, B., Lou, H., Shi, H., & Zhang, X. (2015) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12481 · Cited by 35 · see citing works

Combination delivery of two oxime-loaded lipid nanoparticles: Time-dependent additive action for prolonged rat brain protection

Pashirova, T. N., Braïki, A., Zueva, I. V., Petrov, K. A., Babaev, V. M., Burilova, E. A., Kuznetsova, D. A., Rizvanov, I. K., Souto, E. B., Jean, L., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.010 · Cited by 33 · see citing works

The Use of Anthracyclines for Therapy of CNS Tumors

Ros, M. D., Iorio, A. L., Lucchesi, M., Stival, A., de Martino, M., & Sardi, I. (2015) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520615666150407155319 · Cited by 33 · see citing works

Role of Nanotechnology for Enzyme Replacement Therapy in Lysosomal Diseases. A Focus on Gaucher’s Disease

Martín‐Banderas, L., Holgado, M. A., Durán‐Lobato, M., Infante, J. J., Álvarez‐Fuentes, J., & Arévalo, M. F. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160210130608 · Cited by 33 · see citing works

Berberine-loaded zein/hyaluronic acid composite nanoparticles for efficient brain uptake to alleviate neuro-degeneration in the pilocarpine model of epilepsy

El-Nahas, A. E., Elbedaiwy, H. M., Masoud, I. M., Aly, R. G. M., Helmy, M. W., & El-Kamel, A. H. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.04.008 · Cited by 32 · see citing works

Poly(lactic- co -glycolic acid): The most ardent and flexible candidate in biomedicine!

Roointan, A., Kianpour, S., Memari, F., Gandomani, M., Hayat, S. M. G., & Mohammadi‐Samani, S. (2018) · International Journal of Polymeric Materials · doi:10.1080/00914037.2017.1405350 · Cited by 31 · see citing works

Amifostine-Loaded Nanocarrier Traverses the Blood–Brain Barrier and Prevents Radiation-Induced Brain Injury

Zhao, X., Cheng, J., Gui, S., Jiang, M., Qi, D., Huang, J., Fu, L., Liu, S., Ma, Y., Shi, J., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c00502 · Cited by 30 · see citing works

Gelsolin Amyloidogenesis Is Effectively Modulated by Curcumin and Emetine Conjugated PLGA Nanoparticles

Srivastava, A., Arya, P., Goel, S., Kundu, B., Mishra, P., & Ashish, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127011 · Cited by 30 · see citing works

Thin platelet-like COF nanocomposites for blood brain barrier transport and inhibition of brain metastasis from renal cancer

Zhang, G., Jiang, B., Wu, C., Liu, Y., He, Y., Huang, X., Chen, W., Xi, K., Guo, H., Zhao, X., et al. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00724b · Cited by 29 · see citing works

Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives

Wang, X., Wu, C., Liu, S., & Peng, D. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2069881 · Cited by 29 · see citing works

Nanomedicine and Nanotoxicology: The Pros and Cons for Neurodegeneration and Brain Cancer

Catalan, J., Palma-Florez, S., Álvarez, G., Fritz, H. F., Jara, M. O., & Morales, J. O. (2015) · Nanomedicine · doi:10.2217/nnm.15.189 · Cited by 29 · see citing works

Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications

Portioli, C., Bovi, M., Benati, D., Donini, M., Perduca, M., Romeo, A., Dusi, S., Monaco, H. L., & Bentivoglio, M. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35961 · Cited by 29 · see citing works

Selective Targeting of Cancer Signaling Pathways with Nanomedicines: Challenges and Progress

Barkat, H. A., Das, S. S., Barkat, M. A., Beg, S., & Hadi, H. A. (2020) · Future Oncology · doi:10.2217/fon-2020-0198 · Cited by 28 · see citing works

Optimizing the Design of Blood–Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma

Ahmed, T., Liu, F.-C. F., He, C., Abbasi, A. Z., Cai, P., Rauth, A. M., Henderson, J. T., & Wu, X. Y. (2021) · Pharmaceutical Research · doi:10.1007/s11095-021-03122-9 · Cited by 28 · see citing works

The removal of percutaneous Kirschner wires used in the stabilisation of fractures in children.

Symons, S., Persad, R., & Paterson, M. (2005) · PubMed · Cited by 28 · see citing works

Bionanotechnology and the Future of Glioma

Chiarelli, P., Kievit, F. M., Zhang, M., & Ellenbogen, R. G. (2015) · Surgical Neurology International · doi:10.4103/2152-7806.151334 · Cited by 27 · see citing works

Exosomes for neurodegenerative diseases: diagnosis and targeted therapy

Tao, H., & Gao, B. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12329-w · Cited by 26 · see citing works

Polymeric nanoparticles assembled with microfluidics for drug delivery across the blood-brain barrier

Tavares, M. R., de Menezes, L. R., do Nascimento, D. F., Souza, D. H. S., Reynaud, F., Marques, M. D. F. V., & Tavares, M. I. B. (2016) · The European Physical Journal Special Topics · doi:10.1140/epjst/e2015-50266-2 · Cited by 26 · see citing works

A new preparation strategy for surface modified PLA nanoparticles to enhance uptake by endothelial cells

Raudszus, B., Mulac, D., & Langer, K. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.047 · Cited by 22 · see citing works

Influence of Chronobiology on the Nanoparticle-Mediated Drug Uptake into the Brain

Kreuter, J. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7010003 · Cited by 22 · see citing works

Carbohydrate Nanoparticles for Brain Delivery

Lalatsa, A., & Barbu, E. (2016) · International review of neurobiology · doi:10.1016/bs.irn.2016.05.004 · Cited by 22 · see citing works

Benefits of Nanomedicine for Therapeutic Intervention in Malignant Diseases

Sevastre, A.-S., Horescu, C., Baloi, C., Cioc, C. E., Vatu, B. I., Tuţă, C., Artene, Ş.-A., Dănciulescu, M. M., Tudorache, Ş., & Dricu, A. (2019) · Coatings · doi:10.3390/coatings9100628 · Cited by 22 · see citing works

Artificial intelligence and guidance of medicine in the bubble

Akbar, A., Pillalamarri, N., Jonnakuti, S. T., & Ullah, M. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00623-3 · Cited by 21 · see citing works

Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease

Virameteekul, S., Lees, A. J., & Bhidayasiri, R. (2024) · Movement Disorders · doi:10.1002/mds.29939 · Cited by 20 · see citing works

Behavior of P85 and P188 Poloxamer Molecules: Computer Simulations Using United-Atom Force-Field

Goliaei, A., Lau, E. Y., Adhikari, U., Schwegler, E., & Berkowitz, M. L. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b03030 · Cited by 20 · see citing works

Nanomedicine metaphors: From war to care. Emergence of an oecological approach

Loeve, S., Bensaude‐Vincent, B., & Gazeau, F. (2013) · Nano Today · doi:10.1016/j.nantod.2013.08.003 · Cited by 19 · see citing works

Recent Advancements in Nanocarrier-assisted Brain Delivery of Phytochemicals Against Neurological Diseases

Mishra, K., Rana, R., Tripathi, S., Siddiqui, S., Yadav, P. K., Yadav, P. N., & Chourasia, M. K. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03955-3 · Cited by 18 · see citing works

Influence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain

Kreuter, J. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2003.077 · Cited by 363 · see citing works

From Adsorption to Covalent Bonding: Apolipoprotein E Functionalization of Polymeric Nanoparticles for Drug Delivery Across the Blood–Brain Barrier

Hartl, N., Adams, F., & Merkel, O. M. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000092 · Cited by 155 · see citing works

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.

Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., & Alyautdin, R. (2002) · Journal of drug targeting · doi:10.1080/10611860290031877 · Cited by 801 · see citing works

Transport of drugs across the blood–brain barrier by nanoparticles.

Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715 · see citing works

Nanoparticulate systems for brain delivery of drugs.

Kreuter, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00122-8 · Cited by 1,107 · see citing works